Cetera Investment Advisers Dexcom Inc Transaction History

Cetera Investment Advisers

$49.2 Billion
Q1 2025

A detailed history of Cetera Investment Advisers transactions in Dexcom Inc stock. As of the latest transaction made, Cetera Investment Advisers holds 78,879 shares of DXCM stock, worth $6.76 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

78,879

Previous 72,182 9.28%

Holding current value

$6.76 Million

Previous $5.61 Million 4.04%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 06, 2025	BUY	$67.74 - $90.75 $453,654 - $607,752	6,697 Added 9.28%	78,879 $5.39 Million
Q4 2024 Feb 13, 2025	BUY	$65.68 - $81.01 $682,086 - $841,288	10,385 Added 16.81%	72,182 $5.61 Million
Q3 2024 Nov 13, 2024	SELL	$64.0 - $116.06 $2.2 Million - $3.99 Million	-34,354 Reduced 35.73%	61,797 $4.14 Million
Q2 2024 Aug 22, 2024	SELL	$110.31 - $140.45 $1.18 Million - $1.51 Million	-10,730 Reduced 10.04%	96,151 $10.9 Million
Q1 2024 May 24, 2024	BUY	$114.22 - $140.1 $9.08 Million - $11.1 Million	79,531 Added 290.79%	106,881 $14.8 Million
Q1 2024 May 14, 2024	SELL	$114.22 - $140.1 $3.8 Million - $4.66 Million	-33,234 Reduced 54.86%	27,350 $3.79 Million
Q4 2023 Feb 13, 2024	BUY	$75.49 - $124.16 $476,341 - $783,449	6,310 Added 11.63%	60,584 $7.52 Million
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $680,734 - $1.09 Million	7,910 Added 17.06%	54,274 $5.06 Million
Q2 2023 Aug 09, 2023	SELL	$112.47 - $130.98 $25,193 - $29,339	-224 Reduced 0.48%	46,364 $5.96 Million
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $5,096 - $6,023	-49 Reduced 0.11%	46,588 $5.41 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $1.47 Million - $2.12 Million	17,300 Added 58.97%	46,637 $5.28 Million
Q3 2022 Nov 10, 2022	SELL	$76.35 - $94.18 $225,766 - $278,490	-2,957 Reduced 9.16%	29,337 $2.36 Million
Q2 2022 Aug 11, 2022	BUY	$67.99 - $132.89 $1.65 Million - $3.22 Million	24,233 Added 300.62%	32,294 $2.41 Million
Q1 2022 May 13, 2022	BUY	$94.08 - $130.2 $36,879 - $51,038	392 Added 5.11%	8,061 $4.12 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $58,181 - $72,943	448 Added 6.2%	7,669 $4.12 Million
Q3 2021 Nov 16, 2021	BUY	$106.71 - $143.18 $15,793 - $21,190	148 Added 2.09%	7,221 $3.95 Million
Q2 2021 Aug 13, 2021	BUY	$80.99 - $107.93 $327,766 - $436,792	4,047 Added 133.74%	7,073 $3.02 Million
Q1 2021 May 17, 2021	SELL	$84.79 - $104.74 $203,156 - $250,957	-2,396 Reduced 44.19%	3,026 $1.09 Million
Q4 2020 Feb 17, 2021	BUY	$78.0 - $104.5 $422,916 - $566,599	5,422 New	5,422 $2.01 Million

Others Institutions Holding DXCM

# of Institutions

1,082

Shares Held

362M

Call Options Held

5.4M

Put Options Held

4.3M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $33.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.

Account

Cetera Investment Advisers Dexcom Inc Transaction History